PAVmed (PAVM)
(Delayed Data from NSDQ)
$0.71 USD
0.00 (0.00%)
Updated Jul 5, 2024 03:50 PM ET
4-Sell of 5 4
C Value C Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PAVM 0.71 0.00(0.00%)
Will PAVM be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PAVM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PAVM
Why PAVmed Inc. (PAVM) Dipped More Than Broader Market Today
New Strong Buy Stocks for March 27th
PAVM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why PAVmed Inc. (PAVM) Is a Great 'Buy the Bottom' Stock Now
PAVmed Inc. (PAVM) Upgraded to Buy: Here's Why
PAVmed Inc. (PAVM) Upgraded to Strong Buy: Here's What You Should Know
Other News for PAVM
Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuardĀ® Esophageal Precancer Testing in a Screening Population
12 Health Care Stocks Moving In Monday's After-Market Session
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
12 Health Care Stocks Moving In Thursday's After-Market Session
4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuardĀ® Esophageal Precancer Testing